QT Medical is excited to announce its selection as a Finalist for the prestigious 2024 Digital Health Hub Foundation: Digital Health Awards. QT Medical is a Finalist in the Best in Class – Kids Health category, underscoring its leadership in transforming healthcare for children.

Cardiovascular disease is the second among the top ten causes of death in China. Time is the most important key to treating patients with acute myocardial infarction. In order to assist Taichung to improve emergency rescue energy, the Taiwan Branch of American Merchant Uxin Biomedical Co., Ltd. specially donated 15 sets of 12-lead ECG systems.

QT Medical announces FDA clearance of PCA 500, a resting 12-lead electrocardiogram (ECG or EKG), for use in pediatric patients. First cleared in 2018 for professional and personal use by adults 18 years and older, PCA 500's new FDA clearance expands its indication for use to all pediatric populations, including: newborns, infants, children and adolescents.

QT Medical, Inc. (QT Medical), a medtech company focusing on electrocardiogram (ECG or EKG) technology, announces today that it raised $12 million in Series B financing. This funding will accelerate QT Medical’s market penetration, global expansion, product pipeline development, and long-term strategic planning.

QT Medical is very thrilled to partner with Philips, to bring medical standard 12-lead ECG to patients at home !

QT Medical launches the world’s first 12-lead ECG service for home use - Xpress ECG™

QT Medical launches the worlds first 12-lead ECG service for home use - Xpress ECG™

Rehabmart features the PCA 500 in a Caregiver University article, where they educate doctors by explaining the innovative PCA 500, QT app, QT cloud, and QTM dashboard. Rehabmart highlights the PCA 500’s innovative features and states who exactly could benefit from the device.